查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1302061

脑脊液管理市场：副产品（脑脊液引流、脑脊液分流）、最终用户（成人最终用户、老年最终用户、儿科最终用户） - COVID-19、俄罗斯-乌克兰衝突和高通胀影响的累积 - 2023-2030 年全球预测

Cerebral Spinal Fluid Management Market by Product (CSF Drainage, CSF Shunts), End-User (Adult End Users, Geriatric End Users, Pediatric End Users) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球脑脊液管理市场将达到16.3286亿美元，复合年增长率为6.21%，大幅增长，2030年将达到24.9391亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球脑脊液管理市场至关重要。 通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的决策。 这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场区域的当前状态。 比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。 该分析还揭示了特定行业的竞争程度、积累和分散的优势以及研究基准年的併购特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要公司所服务的市场的全面信息。

2. 市场开发：提供有关利润丰厚的新兴市场的详细信息，并分析其在成熟市场领域的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新开发和投资的详细信息。

4. 市场趋势：全面了解 COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5.竞争评估与信息：对各大公司的市场份额、战略、产品、认证、监管状况、专利状况、製造能力进行综合评估。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

此报告回答了以下问题：

1.脑脊液管理的全球市场规模和预测是多少？

2. 在预测期内，COVID-19 对全球脑脊液管理市场的抑制因素和影响有哪些？

3.在预测期内，全球脑脊液管理市场需要投资哪些产品/细分市场/应用/领域？

4.全球脑脊液管理市场的竞争策略是什么？

5.全球脑脊液管理市场的技术趋势和监管框架是什么？

6.全球脑脊液管理市场主要厂商的市场份额是多少？

7. 哪些形式和战略举措被认为适合进入全球脑脊液管理市场？

目录

第一章前言

第二章研究方法

第 3 章执行摘要

第四章市场概述

第 5 章市场洞察

  • 市场动态
    • 促进因素
      • 婴儿和老年人脑积水和神经系统疾病的患病率增加
      • 后续分流手术数量增加
      • 政府努力改善医疗基础设施
    • 抑制因素
      • 手术费用高
    • 机会
      • CSF 管理的技术进步和发展
      • 对正在进行的与脑屏障和脑液相关的研究项目进行快速投资
    • 作业
      • 缺乏熟练的专业人员和产品召回
  • 市场趋势
  • 新冠肺炎 (COVID-19) 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通胀的累积影响
  • 波特五力分析
  • 价值炼和关键路径分析
  • 监管框架
  • 客户定制

第 6 章脑脊液管理市场：按产品

  • 脑脊液引流
  • 脑脊液分流术

第 7 章脑脊液管理市场：按最终用户划分

  • 成人最终用户
  • 老年最终用户
  • 儿科最终用户

第八章北美和南美脑脊液管理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区脑脊液管理市场

  • 澳大利亚
  • 中国
  • 印度
  • 印度尼西亚
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲的脑脊液管理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 意大利
  • 荷兰
  • 尼日利亚
  • 挪威
  • 波兰
  • 卡塔尔
  • 俄罗斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯联合酋长国
  • 英国

第11章竞争态势

  • FPNV定位矩阵
  • 市场份额分析：按主要公司划分
  • 竞争情景分析：主要公司

第12章上市公司名单

第13章附录

  • 讨论指南
  • 关于许可证和价格
Product Code: MRR-AD36CD89816B

The Global Cerebral Spinal Fluid Management Market is forecasted to grow significantly, with a projected USD 1,632.86 million in 2023 at a CAGR of 6.21% and expected to reach a staggering USD 2,493.91 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cerebral Spinal Fluid Management Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cerebral Spinal Fluid Management Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across CSF Drainage and CSF Shunts. The CSF Drainage is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Adult End Users, Geriatric End Users, and Pediatric End Users. The Geriatric End Users is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cerebral Spinal Fluid Management Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cerebral Spinal Fluid Management Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cerebral Spinal Fluid Management Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cerebral Spinal Fluid Management Market?

4. What is the competitive strategic window for opportunities in the Global Cerebral Spinal Fluid Management Market?

5. What are the technology trends and regulatory frameworks in the Global Cerebral Spinal Fluid Management Market?

6. What is the market share of the leading vendors in the Global Cerebral Spinal Fluid Management Market?

7. What modes and strategic moves are considered suitable for entering the Global Cerebral Spinal Fluid Management Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cerebral Spinal Fluid Management Market, by Product, 2022 vs 2030
  • 4.3. Cerebral Spinal Fluid Management Market, by End-User, 2022 vs 2030
  • 4.4. Cerebral Spinal Fluid Management Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise prevalence of hydrocephalus and neurological disorders among babies and the elderly population
      • 5.1.1.2. Subsequent growth in the number of shunting procedures
      • 5.1.1.3. Government initiative to improve healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of surgical procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and developments in CSF management
      • 5.1.3.2. Rapid investments in ongoing research projects related to brain barriers and brain fluids
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and product recalls
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cerebral Spinal Fluid Management Market, by Product

  • 6.1. Introduction
  • 6.2. CSF Drainage
  • 6.3. CSF Shunts

7. Cerebral Spinal Fluid Management Market, by End-User

  • 7.1. Introduction
  • 7.2. Adult End Users
  • 7.3. Geriatric End Users
  • 7.4. Pediatric End Users

8. Americas Cerebral Spinal Fluid Management Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cerebral Spinal Fluid Management Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cerebral Spinal Fluid Management Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CEREBRAL SPINAL FLUID MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 6. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. CEREBRAL SPINAL FLUID MANAGEMENT MARKET DYNAMICS
  • FIGURE 8. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. CEREBRAL SPINAL FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY CSF DRAINAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 8. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY ADULT END USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY GERIATRIC END USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PEDIATRIC END USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. CEREBRAL SPINAL FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 98. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 99. CEREBRAL SPINAL FLUID MANAGEMENT MARKET LICENSE & PRICING